These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6398307)

  • 1. Carcinogenicity and metabolic activation of tobacco-specific nitrosamines: current status and future prospects.
    Hecht SS; Castonguay A; Chung FL; Hoffmann D
    IARC Sci Publ; 1984; (57):763-78. PubMed ID: 6398307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin adducts as biomarkers of exposure to and metabolic activation of carcinogenic tobacco-specific nitrosamines.
    Hecht SS; Carmella SG; Murphy SE
    Biomed Environ Sci; 1991 Jun; 4(1-2):93-103. PubMed ID: 1910605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
    Tyroller S; Zwickenpflug W; Thalheim C; Richter E
    Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA and hemoglobin adducts as markers of metabolic activation of tobacco-specific carcinogens.
    Foiles PG; Murphy SE; Peterson LA; Carmella SG; Hecht SS
    Cancer Res; 1992 May; 52(9 Suppl):2698s-2701s. PubMed ID: 1563001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to the development of assays for interaction of tobacco-specific nitrosamines with haemoglobin and DNA.
    Hecht SS; Carmella SG; Trushin N; Spratt TE; Foiles PG; Hoffmann D
    IARC Sci Publ; 1988; (89):121-8. PubMed ID: 3198194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis.
    Hecht SS
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):181-91. PubMed ID: 9349687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.
    Hecht SS; Hoffmann D
    Carcinogenesis; 1988 Jun; 9(6):875-84. PubMed ID: 3286030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers.
    Carmella SG; Kagan SS; Kagan M; Foiles PG; Palladino G; Quart AM; Quart E; Hecht SS
    Cancer Res; 1990 Sep; 50(17):5438-45. PubMed ID: 2386948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone released from human haemoglobin as a dosimeter for exposure to tobacco-specific nitrosamines.
    Hecht SS; Kagan SS; Kagan M; Carmella SG
    IARC Sci Publ; 1991; (105):113-8. PubMed ID: 1855833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic alpha-hydroxylation of the tobacco-specific carcinogen, N'-nitrosonornicotine.
    Chen CB; Hecht SS; Hoffmann D
    Cancer Res; 1978 Nov; 38(11 Pt 1):3639-45. PubMed ID: 359127
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N; Hecht SS
    Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.
    Hecht SS; Chen CB; Ohmori T; Hoffmann D
    Cancer Res; 1980 Feb; 40(2):298-302. PubMed ID: 7356512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the evidence that tobacco-specific nitrosamines (TSNA) cause cancer in humans.
    Preston-Martin S
    Crit Rev Toxicol; 1991; 21(4):295-8. PubMed ID: 2069713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
    Stepanov I; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical carcinogenesis: an overview.
    Hecht SS
    Clin Physiol Biochem; 1985; 3(2-3):89-97. PubMed ID: 3891198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens.
    Wang M; Cheng G; Sturla SJ; Shi Y; McIntee EJ; Villalta PW; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2003 May; 16(5):616-26. PubMed ID: 12755591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco specific N-nitrosamines: occurrence and bioassays.
    Hoffmann D; Adams JD; Brunnemann KD; Rivenson A; Hecht SS
    IARC Sci Publ; 1982; (41):309-18. PubMed ID: 6890526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative and quantitative risk assessment of snuff dipping.
    Nilsson R
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis.
    Hoffmann D; Rivenson A; Chung FL; Hecht SS
    Crit Rev Toxicol; 1991; 21(4):305-11. PubMed ID: 2069715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.